Centene's stock plunge offers a potential long-term opportunity. Click here for a full investment analysis of CNC stock.

Centene's stock plunges 40% with EPS slashed by 50%. Discover why valuation may seem cheap but key challenges make CNC stock a cautious investment.

Centene is also witnessing higher medical costs in its Medicaid business, particularly in areas of behavioral health, home health and high-cost drugs, and in certain areas, including New York and ...

Shares of Elevance Health Inc. tumbled toward a more than four-year low Thursday, after the health insurer slashed its full-year profit outlook and said pressures from rising Medicaid and Obamacare ...

The 18-year-old and first-round pick (19th overall) by St. Louis in the 2025 NHL Draft was certainly catching the eye of ...

Today, Benzinga's options scanner spotted 9 options trades for Centene. This isn't normal. The overall sentiment of these big-money traders is split between 66% bullish and 33%, bearish. Out of all of ...

Nearly a week ago, shares of Centene closed down 40.4%, making it the largest single-day drop since the company went public ...

Centene CNC underwent analysis by 11 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. In the table below, you'll find a summary of their recent ratings ...

The market expects Centene (CNC) to deliver a year-over-year decline in earnings on higher revenues when it reports results ...

Analysts have provided mixed ratings on Centene’s stock. Cantor Fitzgerald reiterated an Overweight rating with a $90 price target, citing limited impact from tightened Medicaid work requirements.

Our Top 5 Analyst Questions Centene’s Q1 Earnings Call Josh Raskin (Nephron Research) asked about the nature and containment of flu-related costs.

Shares of Centene Corporation (NYSE:CNC – Get Free Report) hit a new 52-week low during trading on Thursday after Bank of America lowered their price target on the stock from $65.00 to $52.00 ...